CLINICAL TRIALS PROFILE FOR THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER

All Clinical Trials for THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000575 ↗	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	CAMP Steering Committee	Phase 3	1991-09-01	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000575 ↗	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1991-09-01	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000575 ↗	Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)	Completed	Johns Hopkins Bloomberg School of Public Health	Phase 3	1991-09-01	The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000577 ↗	Asthma Clinical Research Network (ACRN)	Withdrawn	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1993-09-01	This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.
NCT00000577 ↗	Asthma Clinical Research Network (ACRN)	Withdrawn	Milton S. Hershey Medical Center	Phase 3	1993-09-01	This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.

Clinical Trial Conditions for THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER

Condition Name

Condition Name for THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
Intervention	Trials
Asthma	22
Chronic Obstructive Pulmonary Disease	9
COPD	8
Lung Diseases	6

Condition MeSH

Condition MeSH for THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
Intervention	Trials
Asthma	20
Lung Diseases	18
Pulmonary Disease, Chronic Obstructive	18
Lung Diseases, Obstructive	14

Clinical Trial Locations for THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER

Trials by Country

Trials by Country for THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
Location	Trials
United States	141
China	24
Japan	19
Canada	13
United Kingdom	12

Trials by US State

Trials by US State for THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
Location	Trials
California	13
Colorado	11
Texas	10
Missouri	9
Tennessee	8

Clinical Trial Progress for THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER

Clinical Trial Phase

Clinical Trial Phase for THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Phase 4	20
Phase 3	19
Phase 2/Phase 3	5

Clinical Trial Status

Clinical Trial Status for THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Completed	68
Unknown status	14
Recruiting	11

Clinical Trial Sponsors for THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER

Sponsor Name

Sponsor Name for THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor	Trials
National Heart, Lung, and Blood Institute (NHLBI)	10
The First Affiliated Hospital of Guangzhou Medical University	4
Boehringer Ingelheim	4

Sponsor Type

Sponsor Type for THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor	Trials
Other	126
Industry	31
NIH	13